What Is a Meningioma?
A meningioma is a tumor that arises from the meninges — the three layers of membrane that surround and protect the brain and spinal cord. While most meningiomas are classified as benign (non-cancerous), they can grow large enough to press on brain tissue, nerves, or blood vessels, causing serious and sometimes life-altering neurological symptoms.
Common symptoms of meningioma include:
- Persistent or worsening headaches
- Vision changes or blurred vision
- Hearing loss or ringing in the ears
- Memory problems and cognitive difficulties
- Weakness in the arms or legs
- Seizures
The Proposed Link to Depo-Provera
Depo-Provera (medroxyprogesterone acetate, or MPA) is a progestogen-based injectable contraceptive. Meningioma tumors are known to express progesterone receptors, which has led researchers to investigate whether long-term exposure to synthetic progestogens like MPA could stimulate tumor growth.
A significant study published in the BMJ (British Medical Journal) found that individuals who used injectable progestogens — including medroxyprogesterone acetate — for extended periods had a meaningfully elevated risk of developing intracranial meningioma compared to non-users. The risk appeared to increase with the duration of use.
How Long-Term Use May Matter
Researchers have noted that the association between Depo-Provera and meningioma risk appears to be dose- and duration-dependent. This means:
- Short-term use may carry a lower or negligible elevated risk.
- Multi-year use (often defined as five or more years in studies) appears to be associated with a more significant increase in risk.
- Risk may persist even after stopping the medication, as tumors can have long latency periods before detection.
What Pfizer and Regulators Have Said
In response to emerging research, some regulatory agencies in Europe updated their prescribing guidance for progestogen-based medications to include meningioma as a potential risk. In the United States, plaintiffs in ongoing litigation allege that Pfizer, the manufacturer of Depo-Provera, knew or should have known about this risk and failed to adequately warn patients and healthcare providers.
Pfizer has disputed liability in these cases. The litigation is ongoing.
Other Serious Side Effects Associated with Depo-Provera
Beyond the meningioma concern, Depo-Provera has a well-documented profile of side effects that users should be aware of:
- Bone Mineral Density Loss: The FDA has issued a black box warning stating that prolonged use can cause significant bone density reduction, which may not be fully reversible.
- Prolonged Infertility: Return to fertility after stopping injections can be delayed by a year or more.
- Depression and Mood Changes: Some users report significant mood disturbances.
- Irregular Bleeding: Unpredictable or absent menstrual periods are common.
What Should You Do If You're Concerned?
If you have used Depo-Provera for an extended period and have been diagnosed with a meningioma or are experiencing neurological symptoms, consider taking the following steps:
- Consult your physician and request appropriate imaging or neurological evaluation.
- Document your Depo-Provera usage history, including dates, dosage, and the healthcare provider who administered it.
- Speak with a mass tort attorney who handles pharmaceutical injury claims to understand your legal options.
This article is for educational purposes only and does not constitute medical or legal advice. Always consult qualified professionals for guidance specific to your situation.